Bethesda category III represents a heterogeneous group in terms of lesion characteristics and the malignancy rates reported in the literature. The objective of the present study was to evaluate …

2020年4月15日 · This paper provides a more precise correlation of malignancy rates with thyroid nodules classified as Bethesda categories III and IV, as our findings are comparable to the …

Owing to the nonnegligible risk of malignancy in AUS/FN/SFN, the American Thyroid Association (ATA) guidelines have recommended 3 possible approaches to management: surveillance …

Introduction: The Bethesda System classifies suspicious thyroid nodules or those with a large size after fine-needle aspiration (FNA) depending on the risk of malignancy through its cytology …

2020年9月1日 · Approximately 25% of thyroid FNA samples are classified as Bethesda category 3 or 4, which are considered cytologically indeterminate 18 and have a malignancy risk of 5% to …

There were 67 nodules classified a second time as Bethesda category III on repeat FNA. We compared malignancy rates, clinicopathologic and ultrasonographic characteristics between …

Patient-centered decision making is increasingly identified as a desirable component of medical care. To manage indeterminate thyroid nodules, patients are offered the options of …

Fine needle aspiration biopsy (FNAB) is the best test for diagnosing cancer outside of surgery; however, the description of FNAB results is di erent across medical centers and pathologists. …

2021年6月24日 · Given the significant variation of treatment choice by physician, standardizing the discussion around the management of Bethesda III and Bethesda IV nodules may help …

The Bethesda system for reporting thyroid cytolopathology standardized reporting thyroid nodules aspirations, but atypia of undetermined significance or follicular lesion of undetermined …